• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

谷氨酰胺代谢的重编程及其对肿瘤微环境中免疫反应的影响。

Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment.

机构信息

Department of Urology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, 266003, China.

Key Laboratory, Department of Urology and Andrology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China.

出版信息

Cell Commun Signal. 2022 Jul 27;20(1):114. doi: 10.1186/s12964-022-00909-0.

DOI:10.1186/s12964-022-00909-0
PMID:35897036
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9327201/
Abstract

Metabolic reprogramming and immune escape play a major role in tumorigenesis. Increasing number of studies have shown that reprogramming of glutamine metabolism is a putative determinant of the anti-tumor immune response in the tumor microenvironment (TME). Usually, the predatory uptake of glutamine by tumor cells in the TME results in the limited utilization of glutamine by immune cells and affects the anti-tumor immune response. The cell-programmed glutamine partitioning also affects the anti-tumor immune response. However, the reprogramming of glutamine metabolism in tumors modulates immune escape by regulating tumor PD-L1 expression. Likewise, the reprogramming of glutamine metabolism in the immune cells also affects their immune function. Additionally, different types of glutamine metabolism inhibitors extensively regulate the immune cells in the TME while suppressing tumor cell proliferation. Herein, we discuss how metabolic reprogramming of tumor and immune cells regulates anti-tumor immune responses, as well as functional changes in different immune cells in the context of targeting tumor glutamine metabolism, which can better explain the potential of targeting glutamine metabolism in combination with immunotherapy for cancer. Video abstract.

摘要

代谢重编程和免疫逃逸在肿瘤发生中起着重要作用。越来越多的研究表明,谷氨酰胺代谢的重编程是肿瘤微环境(TME)中抗肿瘤免疫反应的一个潜在决定因素。通常,TME 中的肿瘤细胞对谷氨酰胺的掠夺性摄取导致免疫细胞对谷氨酰胺的有限利用,并影响抗肿瘤免疫反应。细胞程序性的谷氨酰胺分配也会影响抗肿瘤免疫反应。然而,肿瘤中谷氨酰胺代谢的重编程通过调节肿瘤 PD-L1 表达来调节免疫逃逸。同样,免疫细胞中谷氨酰胺代谢的重编程也会影响它们的免疫功能。此外,不同类型的谷氨酰胺代谢抑制剂在抑制肿瘤细胞增殖的同时,广泛调节 TME 中的免疫细胞。本文讨论了肿瘤和免疫细胞的代谢重编程如何调节抗肿瘤免疫反应,以及在靶向肿瘤谷氨酰胺代谢的情况下不同免疫细胞的功能变化,这可以更好地解释靶向谷氨酰胺代谢与免疫疗法联合治疗癌症的潜力。视频摘要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f347/9327201/04529cfe1870/12964_2022_909_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f347/9327201/3304c9161c0d/12964_2022_909_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f347/9327201/514d4ae30454/12964_2022_909_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f347/9327201/d1785abf1bb3/12964_2022_909_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f347/9327201/04529cfe1870/12964_2022_909_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f347/9327201/3304c9161c0d/12964_2022_909_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f347/9327201/514d4ae30454/12964_2022_909_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f347/9327201/d1785abf1bb3/12964_2022_909_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f347/9327201/04529cfe1870/12964_2022_909_Fig4_HTML.jpg

相似文献

1
Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment.谷氨酰胺代谢的重编程及其对肿瘤微环境中免疫反应的影响。
Cell Commun Signal. 2022 Jul 27;20(1):114. doi: 10.1186/s12964-022-00909-0.
2
A PD-L1-targeting Regulator for Metabolic Reprogramming to Enhance Glutamine Inhibition-Mediated Synergistic Antitumor Metabolic and Immune Therapy.一种针对 PD-L1 的调节剂,用于代谢重编程以增强谷氨酰胺抑制介导的协同抗肿瘤代谢和免疫治疗。
Adv Mater. 2024 Feb;36(6):e2309094. doi: 10.1002/adma.202309094. Epub 2023 Dec 6.
3
Targeted Glucose or Glutamine Metabolic Therapy Combined With PD-1/PD-L1 Checkpoint Blockade Immunotherapy for the Treatment of Tumors - Mechanisms and Strategies.靶向葡萄糖或谷氨酰胺代谢疗法联合PD-1/PD-L1检查点阻断免疫疗法治疗肿瘤——机制与策略
Front Oncol. 2021 Jul 13;11:697894. doi: 10.3389/fonc.2021.697894. eCollection 2021.
4
Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer.胃癌肿瘤微环境代谢重编程在免疫治疗中的作用及机制。
Cell Death Dis. 2022 Apr 20;13(4):378. doi: 10.1038/s41419-022-04821-w.
5
Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.代谢重编程在肿瘤免疫逃逸和免疫治疗中的新作用。
Sci China Life Sci. 2021 Apr;64(4):534-547. doi: 10.1007/s11427-019-1735-4. Epub 2020 Aug 17.
6
The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy.没食子儿茶素没食子酸酯在肿瘤微环境、代谢重编程和免疫治疗中的作用。
Front Immunol. 2024 Jan 29;15:1331641. doi: 10.3389/fimmu.2024.1331641. eCollection 2024.
7
The cancer metabolic reprogramming and immune response.癌症代谢重编程与免疫应答。
Mol Cancer. 2021 Feb 5;20(1):28. doi: 10.1186/s12943-021-01316-8.
8
pH-sensitive tumor-tropism hybrid membrane-coated nanoparticles for reprogramming the tumor microenvironment and boosting the antitumor immunity.用于重编程肿瘤微环境和增强抗肿瘤免疫的 pH 敏感肿瘤趋向性杂化膜包覆的纳米颗粒。
Acta Biomater. 2023 Aug;166:470-484. doi: 10.1016/j.actbio.2023.05.040. Epub 2023 May 28.
9
Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy.肿瘤免疫微环境代谢重编程在结直肠癌进展、免疫逃逸和免疫治疗反应中的作用。
Front Immunol. 2024 Jul 25;15:1353787. doi: 10.3389/fimmu.2024.1353787. eCollection 2024.
10
Metabolic reprogramming of the tumor microenvironment to enhance immunotherapy.肿瘤微环境的代谢重编程以增强免疫疗法。
BMB Rep. 2024 Sep;57(9):388-399. doi: 10.5483/BMBRep.2024-0031.

引用本文的文献

1
Developing a prognostic model of glutamine metabolism-related genes associated with clinical features and immune status in melanoma.构建与黑色素瘤临床特征和免疫状态相关的谷氨酰胺代谢相关基因的预后模型。
Front Oncol. 2025 Aug 20;15:1485006. doi: 10.3389/fonc.2025.1485006. eCollection 2025.
2
The ATF4-glutamine axis: a central node in cancer metabolism, stress adaptation, and therapeutic targeting.ATF4-谷氨酰胺轴:癌症代谢、应激适应及治疗靶点中的核心节点
Cell Death Discov. 2025 Aug 19;11(1):390. doi: 10.1038/s41420-025-02683-7.
3
Baseline metabolic signatures predict clinical outcomes in immunotherapy-treated melanoma patients: a pilot study.

本文引用的文献

1
Inhibitor of glutamine metabolism V9302 promotes ROS-induced autophagic degradation of B7H3 to enhance antitumor immunity.谷氨酰胺代谢抑制剂 V9302 促进 ROS 诱导的 B7H3 自噬降解,增强抗肿瘤免疫。
J Biol Chem. 2022 Apr;298(4):101753. doi: 10.1016/j.jbc.2022.101753. Epub 2022 Feb 19.
2
Meta-analysis of Glutamine on Immune Function and Post-Operative Complications of Patients With Colorectal Cancer.谷氨酰胺对结直肠癌患者免疫功能及术后并发症影响的Meta分析
Front Nutr. 2021 Dec 6;8:765809. doi: 10.3389/fnut.2021.765809. eCollection 2021.
3
Immunosuppression Induced by Glutamine Deprivation Occurs Activating PD-L1 Transcription in Bladder Cancer.
基线代谢特征可预测接受免疫治疗的黑色素瘤患者的临床结局:一项试点研究。
Front Immunol. 2025 Aug 1;16:1536710. doi: 10.3389/fimmu.2025.1536710. eCollection 2025.
4
mTOR Signaling in Macrophages: All Depends on the Context.巨噬细胞中的mTOR信号传导:一切取决于具体情况。
Int J Mol Sci. 2025 Aug 6;26(15):7598. doi: 10.3390/ijms26157598.
5
Sympathetic nervous system in tumor progression and metabolic regulation: mechanisms and clinical potential.肿瘤进展和代谢调节中的交感神经系统:机制与临床潜力
J Transl Med. 2025 Jul 25;23(1):836. doi: 10.1186/s12967-025-06657-2.
6
The Role of Lactate in Immune Regulation: A Metabolic Rheostat via Transporters, Receptors, and Epigenetic Modifiers.乳酸在免疫调节中的作用:通过转运体、受体和表观遗传修饰因子的代谢调节器
Cells. 2025 Jul 17;14(14):1096. doi: 10.3390/cells14141096.
7
Amino acids shape the metabolic and immunologic landscape in the tumor immune microenvironment: from molecular mechanisms to therapeutic strategies.氨基酸塑造肿瘤免疫微环境中的代谢和免疫格局:从分子机制到治疗策略。
Cancer Biol Med. 2025 Jul 24;22(7):726-46. doi: 10.20892/j.issn.2095-3941.2025.0115.
8
Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies.解码肿瘤微环境中的代谢对话:从免疫抑制到精准癌症治疗
Exp Hematol Oncol. 2025 Jul 22;14(1):99. doi: 10.1186/s40164-025-00689-6.
9
Liensinine reshapes the immune microenvironment and enhances immunotherapy by reprogramming metabolism through the AMPK-HIF-1α axis in hepatocellular carcinoma.莲心碱通过激活腺苷酸活化蛋白激酶-低氧诱导因子-1α轴重编程代谢,重塑免疫微环境并增强肝细胞癌的免疫治疗效果。
J Exp Clin Cancer Res. 2025 Jul 15;44(1):208. doi: 10.1186/s13046-025-03477-6.
10
Bi-directional metabolic reprogramming between cancer cells and T cells reshapes the anti-tumor immune response.癌细胞与T细胞之间的双向代谢重编程重塑了抗肿瘤免疫反应。
PLoS Biol. 2025 Jul 14;23(7):e3003284. doi: 10.1371/journal.pbio.3003284. eCollection 2025 Jul.
谷氨酰胺剥夺诱导的免疫抑制通过激活膀胱癌中PD-L1转录而发生。
Front Mol Biosci. 2021 Nov 5;8:687305. doi: 10.3389/fmolb.2021.687305. eCollection 2021.
4
Targeted Glucose or Glutamine Metabolic Therapy Combined With PD-1/PD-L1 Checkpoint Blockade Immunotherapy for the Treatment of Tumors - Mechanisms and Strategies.靶向葡萄糖或谷氨酰胺代谢疗法联合PD-1/PD-L1检查点阻断免疫疗法治疗肿瘤——机制与策略
Front Oncol. 2021 Jul 13;11:697894. doi: 10.3389/fonc.2021.697894. eCollection 2021.
5
Enhancing the Efficacy of Glutamine Metabolism Inhibitors in Cancer Therapy.增强谷氨酰胺代谢抑制剂在癌症治疗中的疗效。
Trends Cancer. 2021 Aug;7(8):790-804. doi: 10.1016/j.trecan.2021.04.003. Epub 2021 May 18.
6
The Metabolic Landscape of RAS-Driven Cancers from biology to therapy.从生物学原理到治疗方法:RAS驱动型癌症的代谢格局
Nat Cancer. 2021 Mar;2(3):271-283. doi: 10.1038/s43018-021-00184-x. Epub 2021 Mar 24.
7
Cell-programmed nutrient partitioning in the tumour microenvironment.肿瘤微环境中的细胞程序性营养分配。
Nature. 2021 May;593(7858):282-288. doi: 10.1038/s41586-021-03442-1. Epub 2021 Apr 7.
8
Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer.选择性谷氨酰胺代谢抑制可提高三阴性乳腺癌肿瘤细胞中抗肿瘤 T 淋巴细胞的活性。
J Clin Invest. 2021 Feb 15;131(4). doi: 10.1172/JCI140100.
9
Lactic Acid and an Acidic Tumor Microenvironment suppress Anticancer Immunity.乳酸和酸性肿瘤微环境抑制抗肿瘤免疫。
Int J Mol Sci. 2020 Nov 7;21(21):8363. doi: 10.3390/ijms21218363.
10
Inhibition of Glutamine Utilization Synergizes with Immune Checkpoint Inhibitor to Promote Antitumor Immunity.抑制谷氨酰胺利用与免疫检查点抑制剂协同作用,促进抗肿瘤免疫。
Mol Cell. 2020 Nov 19;80(4):592-606.e8. doi: 10.1016/j.molcel.2020.10.015. Epub 2020 Nov 6.